Result page for
Nalmefene:
Nalmefene
![1415](./images/1415.png)
General information:
Withdrawal information:
Withdrawn due to drug safety reasons: | No |
First approved: |
1995 |
Side-effects:
Total reported cases (submitted by medical professionals)
with Nalmefene as primary suspect: |
2 |
Reported final outcomes:
Reported side-effects:
Side-effect |
Case number |
Intentional overdose | 2 |
Agitation | 1 |
ASTHENIA | 1 |
DIARRHOEA | 1 |
EPIGASTRIC DISCOMFORT | 1 |
FATIGUE | 1 |
LOOSE STOOLS | 1 |
NAUSEA | 1 |
Suicide attempt | 1 |
VOMITING | 1 |
Filtered ChEMBL targets:
Target UniProtKB ID |
Activity in nm |
Target Name |
Target gene |
P35372 |
0.24 |
Mu-type opioid receptor |
OPRM_HUMAN |
P41143 |
0.912 |
Delta-type opioid receptor |
OPRD_HUMAN |
P41145 |
0.083 |
Kappa-type opioid receptor |
OPRK_HUMAN |
Toxicity information:
Toxicity class: |
4 |
Toxicity type: |
N/A |
LD50: |
402 mg/kg |
External links: